Home > Browse Research > Life Sciences > Pharmaceuticals > Research & Development

Research & Development: market research reports

Research & Development market research reports and industry analysis

Wnt Signaling Pathway in Oncology Drug Pipeline Update 2013 4/22/2013 \| published by: BioSeeker Group AB ... are today 103 companies plus partners developing 109 Wnt pathway targeting drugs in 385 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last ... \| read more...	$3,746.25
Analytical Tool - Breast Cancer 4/22/2013 \| published by: BioSeeker Group AB ... map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies ... \| read more...	$11,625.00
Analytical Tool - Prostate Cancer 4/22/2013 \| published by: BioSeeker Group AB ... map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies ... \| read more...	$11,625.00
Apoptosis in Oncology Drug Pipeline Update 2013 4/22/2013 \| published by: BioSeeker Group AB ... cancer cells. There are today 282 companies plus partners developing 277 apoptotic drugs in 1179 developmental projects in cancer. In addition, there are 9 suspended drugs and the accumulated number of ceased drugs over the ... \| read more...	$5,621.25
China Pharmaceutical Guidebook Series (2) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Chemical Drugs 4/20/2013 \| published by: Access China Management Consulting Ltd. ... to the imported drugs from overseas pharmaceutical manufacturers and producers. By 2012, sales of imported drugs have shared one fourth on the Chinese drug market. As China joins the World Trade Organization (WTO) and integrates ... \| read more...	$750.00
The Hepatitis C Market Outlook to 2022 4/17/2013 \| published by: Datamonitor ... five major EU markets. The sales trends of key marketed and pipeline brands and the anticipated shift in the treatment paradigm are assessed from 2013–2022. Features and benefits PDF with forecasts through to 2022 covering ... \| read more...	$4,500.00
Alzheimer Disease Treatment Drugs Markets in China 4/15/2013 \| published by: Asia Market Information & Development Company ... continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term ... \| read more...	$2,000.00
EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 4/12/2013 \| published by: GlobalData ... a histologic and/or radiologic pattern of usual interstitial pneumonia (NHLBI, 2011; Raghu et al., 2011). As a fatal disease that falls under the umbrella of interstitial lung disease of unknown cause, IPF is limited to ... \| read more...	$3,995.00
EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022 4/12/2013 \| published by: GlobalData ... in the bone marrow that invade the blood and potentially other organs, depending on the phase of the cancer (ACS, 2012; NLM, 2012). Based on clinical characteristics and laboratory findings, CML is divided into three ... \| read more...	$3,995.00
Chinese Pharmaceutical Market 2013-2023 4/9/2013 \| published by: Visiongain ... also explains medical and technological trends, prospects and commercial opportunities. Our study lets you assess sales data and detailed predictions. There, you investigate activities of domestic and international companies and assess their environment. That analysis ... \| read more...	$2,738.00
New Product Development Trends in Consumer Health 2013 4/9/2013 \| published by: Euromonitor International ... busy lifestyles are driving the popularity of energy and calming products, as well as on-the-go delivery mechanisms. Economic uncertainty is creating more demand for cheaper options, while preventive treatments are addressing critical public health issues. ... \| read more...	$2,000.00
Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth 4/8/2013 \| published by: GBI Research ... its latest research report, entitled “Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth”. The report provides insights into the ... \| read more...	$3,500.00
Conference Documentation: Adaptive Designs in Clinical Trials 4/8/2013 \| published by: SMI Publishing, Ltd ... and improve the overall clinical accuracy. Successful implementation of adaptive designs into a trial however requires unparalleled coordination between clinicians, trial managers, statisticians and those involved in external and internal regulation. Our expert speakers are ... \| read more...	$788.78
Companion Diagnostics – Streamlining Drug Development and Advancing Personalized Medicine 4/1/2013 \| published by: CBR Pharma Insights, LLC ... to gain ground. Companion diagnostics can be used in screening, monitoring, diagnosing and treating patients and can allow for stratification of patients to maximize efficacy and minimize risk Companion diagnostics can allow for a specific ... \| read more...	$3,900.00
Global Fabry's Disease Pipeline Capsule - 2013 4/1/2013 \| published by: Fore Pharma ... and drug discovery. Global Fabry's Disease Pipeline Capsule 2013' helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and ... \| read more...	$690.00
R&D Productivity – The State of Research and Development in the BioPharmaceutical Industry (CBRSV043) 4/1/2013 \| published by: CBR Pharma Insights, LLC ... from? Is spend decreasing? If spend is decreasing, what impact is this having on R&D? What can be done to encourage innovation in the biotech and pharmaceutical industry? Is the biotech model of R&D better ... \| read more...	$3,900.00
Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 4/1/2013 \| published by: GlobalData ... to life-threatening lung infections; and obstructs pancreatic enzyme secretions that are essential for the body to break down and absorb nutrients. CF patients have a limited number of available treatment options and significant unmet needs ... \| read more...	$5,995.00
E-Clinical Trial Technologies 4/1/2013 \| published by: Global Industry Analysts ... Trial Supply Management (RTSM), and Interactive Response Technology (IRT). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period ... \| read more...	$4,450.00
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013 4/1/2013 \| published by: GlobalData ... data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on partnerships, licensing agreements, M&As, equity/debt offerings, private equity and venture ... \| read more...	$1,500.00
Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017 4/1/2013 \| published by: GlobalData ... in older adults’ =50 years old, with an abysmal prognosis (3-5 years following diagnosis). After decades of being an underserved therapeutic arena, the IPF treatment landscape is set to dramatically change with the anticipated approval ... \| read more...	$5,995.00
Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry 4/1/2013 \| published by: GlobalData ... the Pharmaceutical Industry report provides a cross-section of major licensing deals between mid to large-sized pharmaceutical companies and academic and nonprofit research institutions. This report examines the terms, platform technologies, and deal rationale of 25 ... \| read more...	$2,995.00
Global Irritable Bowel Syndrome (IBS) Market: Trends & Opportunities (2012-2017) 4/1/2013 \| published by: Daedal Research ... predicts the future growth of the market. The report also analyzes the various sub segments of the market and the worldwide sales of drugs available for the specific segment. Besides presenting the competitive landscape, the ... \| read more...	$700.00
PharmaPoint: Multiple Sclerosis - France Drug Forecast and Market Analysis to 2022 3/31/2013 \| published by: GlobalData ... (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying ... \| read more...	$4,995.00
PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market Analysis to 2022 3/31/2013 \| published by: GlobalData ... sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with ... \| read more...	$4,995.00
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 3/31/2013 \| published by: GlobalData ... Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy ... \| read more...	$4,995.00

< prev 1 2 3 4 5 6 7 8 9 10 next >